Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany
Health Outcomes Research in Medicine · 2011
DOI: 10.1016/j.ehrm.2011.02.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Outcomes Research in Medicine, 2011. Verfasst von Martin Pfohl und 4 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Pfohl, M., Dippel, F., Kostev, K., Fuchs, S., & Kotowa, W. (2011). Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany. Health Outcomes Research in Medicine. https://doi.org/10.1016/j.ehrm.2011.02.001
Vancouver
Pfohl M, Dippel F, Kostev K, Fuchs S, Kotowa W. Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany. Health Outcomes Research in Medicine. 2011. doi:10.1016/j.ehrm.2011.02.001
BibTeX
@article{Pfohl2011,
author = {Pfohl, Martin and Dippel, Franz-Werner and Kostev, Karel and Fuchs, Sabine and Kotowa, Wioletta},
title = {Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany},
journal = {Health Outcomes Research in Medicine},
year = {2011},
doi = {10.1016/j.ehrm.2011.02.001}
}
EUVIMED